Rhythm Pharmaceuticals Inc. (RYTM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rhythm Pharmaceuticals In...

    NASDAQ: RYTM · Real-Time Price · USD
    101.44
    1.67 (1.67%)
    At close: Sep 09, 2025, 3:59 PM
    99.00
    -2.41%
    After-hours: Sep 09, 2025, 06:42 PM EDT

    Rhythm Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 130.13M 77.43M 23.64M 3.15M
    Cost of Revenue
    		 13.37M 9.3M 2.13M 599K
    Gross Profit
    		 116.76M 68.13M 21.5M 2.56M
    Operating Income
    		 -265.5M -184.36M -179.16M -170.06M
    Interest Income
    		 14.71M 13.95M 4.03M 447K
    Pretax Income
    		 -260.26M -184.11M -181.12M -69.61M
    Net Income
    		 -260.6M -184.68M -181.12M -69.61M
    Selling & General & Admin
    		 144.3M 117.53M 92.03M 68.49M
    Research & Development
    		 237.96M 134.95M 108.63M 104.13M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 382.26M 252.48M 200.66M 172.61M
    Interest Expense
    		 20.6M 13.89M 5.2M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 395.63M 261.79M 202.79M 173.21M
    Income Tax Expense
    		 346K 564K n/a n/a
    Shares Outstanding (Basic)
    		 60.99M 57.67M 52.12M 49.6M
    Shares Outstanding (Diluted)
    		 60.99M 57.67M 52.12M 49.6M
    EPS (Basic)
    		 -4.21 -3.2 -3.51 -1.37
    EPS (Diluted)
    		 -4.21 -3.2 -3.51 -1.37
    EBITDA
    		 -238.09M -168.46M -174.25M -68.45M
    EBIT
    		 -239.65M -170.22M -175.92M -69.61M
    Depreciation & Amortization
    		 1.56M 1.76M 1.67M 1.16M

    Add to Watchlist